MAX Chat
Company Analysis Solara Active Pharma Sciences Limited
1. Summary
Advantages
- Price (505.9 βΉ) is less than fair price (635.42 βΉ)
Disadvantages
- Dividends (0%) are below the sector average (0.6581%).
- The stock's return over the last year (-27.27%) is lower than the sector average (0%).
- Current debt level 42.59% has increased over 5 years from 0%.
- The company's current efficiency (ROE=-46.55%) is lower than the sector average (ROE=3.58%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Solara Active Pharma Sciences Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 6.7% | 3.1% | -0.5% |
| 90 days | -0.8% | 16.9% | 3.3% |
| 1 year | -27.3% | 0% | 2.2% |
SOLARA vs Sector: Solara Active Pharma Sciences Limited has significantly underperformed the "Healthcare" sector by -27.27% over the past year.
SOLARA vs Market: Solara Active Pharma Sciences Limited has significantly underperformed the market by -29.46% over the past year.
Stable price: SOLARA is not significantly more volatile than the rest of the market on "Bombay Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SOLARA with weekly volatility of -0.5245% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (505.9 βΉ) is lower than the fair price (635.42 βΉ).
Price significantly below the fair price: The current price (505.9 βΉ) is 25.6% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (56.1).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (44.6).
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.59) is lower than that of the sector as a whole (8.11).
P/BV vs Market: The company's P/BV (1.59) is lower than that of the market as a whole (5.33).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.2) is lower than that of the sector as a whole (17.81).
P/S vs Market: The company's P/S indicator (1.2) is lower than that of the market as a whole (8.99).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (14.19) is higher than that of the sector as a whole (4.22).
EV/Ebitda vs Market: The company's EV/Ebitda (14.19) is lower than that of the market as a whole (15.13).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -119.01% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-119.01%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-17.15%).
5.4. ROE
ROE vs Sector: The company's ROE (-46.55%) is lower than that of the sector as a whole (3.58%).
ROE vs Market: The company's ROE (-46.55%) is lower than that of the market as a whole (-1.52%).
5.5. ROA
ROA vs Sector: The company's ROA (-21.63%) is lower than that of the sector as a whole (3.38%).
ROA vs Market: The company's ROA (-21.63%) is lower than that of the market as a whole (7.42%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (13.38%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (13.44%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.6581%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.6.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
